peptide elongation factor 2 has been researched along with Lupus Erythematosus, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alberdi, F; Dadone, J; Isenberg, DA; Ravirajan, C; Reichlin, M; Ryazanov, A | 1 |
| Elkon, K; Kominami, R; Traut, RR; Uchiumi, T | 1 |
2 other study(ies) available for peptide elongation factor 2 and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Cross-reaction of lupus anti-dsDNA antibodies with protein translation factor EF-2.
Topics: Animals; Antibodies, Antinuclear; Antibodies, Monoclonal; Antibody Specificity; Autoantigens; Autoimmune Diseases; Cattle; Cross Reactions; DNA; HeLa Cells; Humans; Immunoglobulin G; Liver; Lupus Erythematosus, Systemic; Peptide Elongation Factor 2; Protein Biosynthesis; Rabbits; Ribosomal Proteins | 2001 |
A human autoantibody specific for a unique conserved region of 28 S ribosomal RNA inhibits the interaction of elongation factors 1 alpha and 2 with ribosomes.
Topics: Animals; Antibody Specificity; Autoantibodies; Base Sequence; HeLa Cells; Humans; Lupus Erythematosus, Systemic; Mice; Molecular Sequence Data; Nucleic Acid Conformation; Peptide Biosynthesis; Peptide Elongation Factor 1; Peptide Elongation Factor 2; Peptide Elongation Factors; Peptides; Precipitin Tests; Restriction Mapping; Ribosomes; RNA, Ribosomal, 28S; Sequence Homology, Nucleic Acid | 1991 |